NIIMBL Announces First Faculty Fellows Program Recipient: Dr. Sarah W. Harcum

NEWARK, Del., December 20, 2022 /PRNewswire/ — Today, the National Institute for Innovation in Biopharmaceutical Manufacturing (NIIMBL) announced the first recipient of its new Faculty Fellows Program, Dr. Sarah W. Harcum of Clemson University. The NIIMBL Faculty Fellows Program is a pilot program that provides financial support to university and community college faculty and professors to undertake a sabbatical with NIIMBL industry member organizations or directly with NIIMBL.

The Faculty Fellows program facilitates a greater level of collaboration between academia and industry. Dr. Harcum will share his cell culture experience with the Process Intensification (PI) Testbed team and gain hands-on experience in protein purification.

“In order to grow and innovate at the speed required by our modern world, collaboration is essential. Bringing together experts from diverse backgrounds and mindsets, in this case academia and industry, has proven to be a formula that accelerates innovation and bridges the gap between academic research and industry’s needs,” he said. John BalchunasDirector of staff development at NIIMBL.

The objective of the NIIMBL Faculty Fellows Program is to create a diverse and engaged community of academics that can work collaboratively and effectively with industry. NIIMBL Faculty Fellows will gain valuable experience and exposure to cutting-edge biopharmaceutical manufacturing, learn about real-world industry challenges, forge new industry-academia partnerships, and strengthen the entire member community.

From January December 2023Dr. Harcum will work with the industry leaders who designed the PI Testbed at the NIIMBL headquarters. Newark, Delaware, to better understand the barriers to commercial adoption of continuous biomanufacturing. Dr. Harcum has been a teacher Clemson University Since 2002, currently in Bioengineering. Before ClemsonHe worked at the United States Food and Drug Administration in the Division of Monoclonal Antibodies and at New Mexico State University Joint appointment in Molecular Biology in Chemical Engineering.

NIIMBL opened a request for proposals for the Faculty Fellows Program March 2022 and continues to accept applications December 31, 2022.

Visit for more program information and to learn more about NIIMBL.


The National Institute for Innovation in Biopharmaceutical Manufacturing (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, develop standards that enable more efficient and faster manufacturing capabilities, and educate and train the world’s leading biopharmaceutical manufacturing workforce. while essentially advancing US competitiveness in this industry. It is part of NIIMBL Manufacturing USA®a diverse network of federally sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the United States Department of Commerce’s National Institute of Standards and Technology (NIST) with significant additional support from its members.

The news
Maria X. Chacon
Marketing and Communications Director
[email protected]

SOURCE National Institute for Innovation of Biopharmaceutical Products (NIIMBL)

Leave a Comment